Vimarsana
Biggest News Aggregation in the World

Page 2 - Replimune Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Replimune Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Replimune Group Today - Breaking & Trending Today

Replimune Group (NASDAQ:REPL) and Zura Bio (NASDAQ:ZURA) Head-To-Head Comparison - Vimarsana News

Replimune Group (NASDAQ:REPL) and Zura Bio (NASDAQ:ZURA) Head-To-Head Comparison

Zura Bio (NASDAQ:ZURA – Get Free Report) and Replimune Group (NASDAQ:REPL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Insider & Institutional Ownership 61.1% of Zura […]

Head-To-Head Survey: Replimune Group (NASDAQ:REPL) & Zura Bio (NASDAQ:ZURA) - Vimarsana News

Head-To-Head Survey: Replimune Group (NASDAQ:REPL) & Zura Bio (NASDAQ:ZURA)

Replimune Group (NASDAQ:REPL – Get Free Report) and Zura Bio (NASDAQ:ZURA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Risk & Volatility Replimune Group has a […]

Source: wkrb13.com
Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO - Vimarsana News

Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO

(RTTNews) - Biotechnology company Replimune Group, Inc. (REPL) announced Tuesday changes to its executive leadership team designed to support the ...

Profund Advisors LLC Grows Stock Position in Replimune Group, Inc. (NASDAQ:REPL) - Vimarsana News

Profund Advisors LLC Grows Stock Position in Replimune Group, Inc. (NASDAQ:REPL)

Profund Advisors LLC lifted its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 19.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,557 shares of the company’s stock after purchasing an additional 5,045 shares during the quarter. Profund Advisors […]

Source: wkrb13.com
12 Best Medical Stocks to Buy Under $10 - Insider Monkey - Vimarsana News

12 Best Medical Stocks to Buy Under $10 - Insider Monkey

In this article, we will take a look at the 12 best medical stocks to buy under $10.